Sonelokimab
Product Specifications
CAS Number
1414386-05-2
Target
Interleukin|||MMP
Related Pathways
Proteases/Proteasome|||Immunology/Inflammation
Bioactivity
Sonelokimab (ALX 0761; M 1095) is a trivalent nanobody combining monovalent camelid-derived nanobodies targeting human interleukin (IL) -17A and IL-17F with human serum albumin VHHs, presenting it as a promising candidate for investigating plaque-type psoriasis treatments [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL306196V 500 µL Each
C14orf135 (PCNX4) Human shRNA Lentiviral Particle (Locus ID 64430)
Ask
View Details 
MBS6191797-01 0.1 mL
PI15 (Peptidase Inhibitor 15, PI-15, 25kD Trypsin Inhibitor, p25TI, Cysteine-rich Secretory Protein 8, CRISP-8, SugarCrisp, CRISP8, P25TI, DKFZp686F0366, P24TI) (MaxLight 405)
Ask
View Details 
MBS6191797-02 5x 0.1 mL
PI15 (Peptidase Inhibitor 15, PI-15, 25kD Trypsin Inhibitor, p25TI, Cysteine-rich Secretory Protein 8, CRISP-8, SugarCrisp, CRISP8, P25TI, DKFZp686F0366, P24TI) (MaxLight 405)
Ask
View Details MBS1098548-01 0.02 mg (E-Coli)
Recombinant Rhodobacter sphaeroides Glutamate--tRNA ligase 2 (gltX2)
Ask
View Details 
MBS1098548-02 0.02 mg (Yeast)
Recombinant Rhodobacter sphaeroides Glutamate--tRNA ligase 2 (gltX2)
Ask
View Details MBS1098548-03 0.1 mg (E-Coli)
Recombinant Rhodobacter sphaeroides Glutamate--tRNA ligase 2 (gltX2)
Ask
View Details